Pfizer

Politician(s) lobbied: Simon Harris (Tánaiste and Minister), Department of Foreign Affairs; John Hogan (Secretary General), Department of Finance; Conor Glynn (Special Advisor to the Tanaiste), Department of the Taoiseach; Sinead Ryan (Assistant Secretary), Department of Finance

Intent: Ensure Ireland remains vocal against tariffs/ retaliatory tariffs on medicines and pharmaceutical ingredients; Ensure Ireland understands potential impacts of MFN policy and recognises the need for Ireland (and Europe) to appropriately value innovation closing the gap between Europe and the US; in Ireland specifically the Framework Supply Agreement and RSV immunisation

Methods: MeetingEmail

Politician(s) lobbied: Peter Burke (Minister), Department of Enterprise, Trade and Employment; Brian Keegan (Special Advisor), Department of Enterprise, Trade and Employment

Intent: Reform of R&D tax credit to ensure that Ireland remains competitive in attracting pharmaceutical investment and to support industry innovation.

Methods: Meeting

Politician(s) lobbied: Simon Harris (An Taoiseach), Department of the Taoiseach; Micheál Martin (Tánaiste and Minister), Department of Foreign Affairs; Jennifer Carroll MacNeill (Minister), Department of Health; Pádraig O'Sullivan (TD), Dáil Éireann, the Oireachtas; Colm Burke (TD), Dáil Éireann, the Oireachtas; Shane Moynihan (TD), Dáil Éireann, the Oireachtas; Pádraig Rice (TD), Dáil Éireann, the Oireachtas; Marie Sherlock (TD), Dáil Éireann, the Oireachtas; Emer Currie (TD), Dáil Éireann, the Oireachtas

Intent: To highlight the importance of reform of the reimbursement system so that patients can access new medicines as soon as possible::That the state will speed up access to medicines and increase investment in innovative medicines in the context of the IPHA framework agreement re-negotiations

Methods: EmailLetterMeeting

Politician(s) lobbied: Micheál Martin (An Taoiseach), Department of the Taoiseach; Joanne Lonergan (Programme Manager - Tánaiste), Department of the Taoiseach; Deirdre Gillane (Chief of Staff), Department of the Taoiseach; Simon Harris (Tánaiste and Minister), Department of Defence; Peter Burke (Minister), Department of Enterprise, Trade and Employment; Geraldine Byrne Nason (Ambassador), Department of Foreign Affairs; Conor Glynn (Special Advisor to the Tanaiste), Department of the Taoiseach; Shane Moynihan (TD), Dáil Éireann, the Oireachtas; Colm Burke (TD), Dáil Éireann, the Oireachtas; Clare Mungovan (Special Adviser), Department of the Taoiseach; Seamus McGrath (TD), Dáil Éireann, the Oireachtas

Intent: To highlight our concerns about the inclusion of pharmaceuticals in tariffs, the timing for entry into force, and the need for a zero-tariff pathway that includes innovative medicines. ::To highlight the potential impact of Most Favoured Nation pricing for pharmaceuticals in the US and the need for further investment in innovative medicines in Europe that recognises the value of biopharmaceutical innovation

Methods: MeetingEmailPhone call

Politician(s) lobbied: Jennifer Carroll MacNeill (Minister), Department of Health; Kieran O'Donnell (Minister of State), Department of Housing, Local Government and Heritage; Jennifer Murnane O'Connor (TD), Dáil Éireann, the Oireachtas; Professor Mary Horgan (Chief Medical Officer), Department of Health; Shane Moynihan (TD), Dáil Éireann, the Oireachtas; Colm Burke (TD), Dáil Éireann, the Oireachtas; Pádraig O'Sullivan (TD), Dáil Éireann, the Oireachtas; Martin Daly (TD), Dáil Éireann, the Oireachtas; Jerry Buttimer (Minister of State), Department of Rural and Community Development

Intent: Highlight the importance of the roll-out of an RSV National Immunisation Programme for those over 65 years old to reduce the burden of RSV disease which continues to cause illness and hospitalisation among infants and older adults. The spread of RSV is of particular concern in nursing homes and residential healthcare settings and can lead to further respiratory complications for older people. ::Expansion of the infant programme to include a maternal vaccine so that parents have the opportunity to choose between a mother receiving a vaccine during pregnancy or the newborn baby receiving a monoclonal antibody

Methods: EmailLetterMeeting

Politician(s) lobbied: Pádraig O'Sullivan (TD), Dáil Éireann, the Oireachtas

Intent: To highlight the importance of timely access to genetic testing for those with ATTR-CM in Ireland

Methods: Email

Politician(s) lobbied: Peter Burke (Minister), Department of Enterprise, Trade and Employment; Micheál Martin (Taoiseach), Dáil Éireann, the Oireachtas; Simon Harris (Tánaiste and Minister), Department of Foreign Affairs; Jennifer Carroll MacNeill (Minister), Department of Health; Laura Mannion (Special Adviser), Department of Enterprise, Trade and Employment; Deirdre Gillane (Chief of Staff), Department of the Taoiseach; Billy Kelleher (MEP), European Parliament

Intent: Highlight negative impact of changes to the EU Pharmaceutical legislation on the Irish economy and EU competitiveness

Methods: EmailLetterMeeting

Politician(s) lobbied: Simon Harris (An Taoiseach), Department of the Taoiseach; Micheál Martin (Tánaiste and Minister), Department of Foreign Affairs; David Cullinane (TD), Dáil Éireann, the Oireachtas; Jennifer Carroll MacNeill (Minister), Department of Health; Laura Mannion (Special Adviser), Department of Enterprise, Trade and Employment; Peter Burke (Minister), Department of Enterprise, Trade and Employment; Pádraig O'Sullivan (TD), Dáil Éireann, the Oireachtas

Intent: To implement the Mazar's reimbursement review recommendations and publish the working group report ::Faster access to new medicines for patients

Methods: EmailLetterMeeting

Politician(s) lobbied: Micheál Martin (An Taoiseach), Department of the Taoiseach; Simon Harris (Tánaiste and Minister), Department of Foreign Affairs; Jennifer Carroll MacNeill (Minister), Department of Health; Peter Burke (Minister), Department of Enterprise, Trade and Employment; Laura Mannion (Special Advisor), Department of Enterprise, Trade and Employment; David Cullinane (TD), Dáil Éireann, the Oireachtas

Intent: Highlight the importance of the roll-out of an RSV National Immunisation Programme for those over 65 years old to reduce the burden of RSV disease which continues to cause illness and hospitalisation among infants and older adults. The spread of RSV is of particular concern in nursing homes and residential healthcare settings and can lead to further respiratory complications for older people. ::Expansion of the infant programme to include a maternal vaccine so that parents have the opportunity to choose between a mother receiving a vaccine during pregnancy or the newborn baby receiving a monoclonal antibody

Methods: EmailLetter

Politician(s) lobbied: Micheál Martin (An Taoiseach), Department of the Taoiseach; Joanne Lonergan (Programme Manager - Tánaiste), Department of the Taoiseach; Pauric McPhillips (Special Advisor to the Tanaiste), Department of the Taoiseach; Deirdre Gillane (Chief of Staff), Department of the Taoiseach; Diarmuid Lynch (Special Adviser), Department of the Taoiseach; Paschal Donohoe (Minister), Department of Public Expenditure, NDP Delivery and Reform; Simon Harris (Tánaiste and Minister), Department of Defence; Peter Burke (Minister), Department of Enterprise, Trade and Employment; Laura Mannion (Special Advisor), Department of Enterprise, Trade and Employment; Billy Kelleher (MEP), European Parliament; Geraldine Byrne Nason (Ambassador), Department of Foreign Affairs

Intent: To highlight that tariffs on medicines and their inputs would increase healthcare costs for patients and increase the cost of producing medicines, reducing the competitiveness of pharmaceutical manufacturers that drive innovation. Globally integrated supply chains for medicines means that the impact of tariffs cannot be limited to one country. ::Ensuring pharmaceuticals are exempt from any potential retaliatory tariffs because suchmeasures have a cumulative negative impact, increasing the cost of production andreducing patient access.

Methods: EmailMeetingPhone call